Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Burkitt Lymphoma × Dexamethasone × Clear all

Phase

Status

Completed 19 Active not recruiting 8 Terminated 6 Recruiting 6 Unknown 3 Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Burkitt Lymphoma 1

Interventions

pegaspargase 1 Vincristine 1 Thioguanine 1 Rituximab 1 RFB4(dsFv)-PE38 recombinant immunotoxin 1 Methotrexate 1 Mercaptopurine 1 Inotuzumab Ozogamicin 1 Doxorubicin 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Biopsy 1 Antibodies, Monoclonal 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03150693 2026-03-02

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡